Stock Region Penny Picks
Stock Region Watchlist Newsletter - Tuesday, January 21, 2025
Stock Region Penny Picks Watchlist Newsletter - Tuesday, January 21, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for informational purposes only and should not be considered as financial advice. Please conduct your own research or consult a financial advisor before making any investment decisions.
Today's Highlights
$HSDT - Helius Medical Technologies, Inc.
Helius has exceeded its initial enrollment target for a pivotal stroke study, showcasing strong interest and progress in advancing its groundbreaking medical technologies. Positive updates here could spur investor confidence.
$INM - InMed Pharmaceuticals
Results from a preclinical Alzheimer’s study reveal that INM-901 reduces neuroinflammation significantly. Promising advancements in the high-interest neurodegenerative disease space could drive momentum for the stock.
$GNS - Genius Group
Genius Group announced the purchase of 420 Bitcoin valued at $40 million, solidifying its focus on cryptocurrency diversification. This move aligns with the growing trend of corporate Bitcoin treasury strategies.
$DRMA - Dermata Therapeutics
Dermata is collaborating with Revance on clinical trials for the topical application of Xyngari(TM) alongside Daxxify(R). This partnership aims to unlock new skincare treatments, marking an expansion of their therapeutic portfolio.
$HOTH - Hoth Therapeutics
Hoth bolsters its intellectual property by acquiring new patent applications. Strengthening its IP portfolio may signal a strategic step toward innovation and long-term growth.
$ASNS - Actelis Networks
The company secured a major order ahead of the next NRTS phase, positioning itself for future opportunities. This is a potential indication of further market traction.
$XTIA - XTI Aerospace
XTI Aerospace gains access to one of the fastest supercomputers globally to drive the development of its TriFan 600. This leap in technology could accelerate progress in the aerospace industry.
$SONN - Sonnet BioTherapeutics
Sonnet is expanding its SB101 trial by testing SON-1010 in combination with Trabectedin for certain sarcomas. This development could broaden treatment options and add value to its clinical pipeline.
$GOEV - Canoo
Canoo has filed for bankruptcy, ceasing operations after failing to secure financial backing. Unsuccessful funding efforts, including from the Department of Energy, led to this outcome. Investors should take caution surrounding this news.
$VATE - INNOVATE Corp.
INNOVATE has secured FDA approval of MediBeacon's TGFR System for kidney function testing. This milestone could bolster its product lineup and market potential.
$VERI - Veritone, Inc.
Veritone has been granted a U.S. patent for "Neural Network Orchestration," potentially enhancing its competitive edge and value proposition in the AI space.
Disclaimer: All stock information presented is subject to change and may involve risks. Stock Region does not guarantee the accuracy of this information or take responsibility for any losses sustained from trading decisions made based on this newsletter.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net